Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B.

Baran, Bulent; Soyer, Ozlem Mutluay; Ormeci, Asli Cifcibasi; Gokturk, Suut; Evirgen, Sami; Bozbey, Hamza Ugur; Akyuz, Filiz; Karaca, Cetin; Demir, Kadir; Besisik, Fatih; Onel, Derya; Gulluoglu, Mine; Badur, Selim; Kaymakoglu, Sabahattin

Baran, Bulent; Soyer, Ozlem Mutluay; Ormeci, Asli Cifcibasi; Gokturk, Suut; Evirgen, Sami; Bozbey, Hamza Ugur; Akyuz, Filiz; Karaca, Cetin; Demir, Kadir; Besisik, Fatih; Onel, Derya; Gulluoglu, Mine; Badur, Selim; Kaymakoglu, Sabahattin.

Affiliation

Baran B; Department of Gastroenterohepatology, Istanbul University, Istanbul Faculty of Medicine, Capa, Istanbul, Turkey.

Antimicrob Agents Chemother ; 57(4): 1790-6, 2013 Apr.

Article de En | MEDLINE | ID: mdl-23380725

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Adénine / Lamivudine / Hépatite B chronique / Phosphonates / Nucléosides / Nucléotides Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: Antimicrob Agents Chemother Année: 2013 Type de document: Article Pays d'affiliation: Turquie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google